🔴 Oncolytics Biotech is trading 5% down today with no clear catalyst

Oncolytics Biotech is trading 5% down at $0.80, with no clear company-specific catalyst identified for September 8, 2026.

• The broader market is also weaker: the S&P 500, Nasdaq Composite, and Dow Jones declined 0.36%, 0.43%, and 0.81%, respectively, but those moves do not establish a clear cause.
• The latest notable update was positive FDA feedback announced August 18, 2026, not a negative event; the decline may reflect trading-specific pressure.